Xerostomia Therapeutics Market Size to Reach USD 2,993.61 Million by 2034 with 3.5% CAGR
The global xerostomia therapeutics market is gaining momentum as rising prevalence of dry mouth conditions, growing elderly populations, and increased awareness of oral health drive demand for effective treatment options. Xerostomia, commonly known as dry mouth, is caused by reduced or absent saliva production and can result from medical treatments, chronic conditions, or medication side...
0 Commentaires 0 parts